A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)

Trial Identifier: D6187C00001
Sponsor: AstraZeneca
Start Date: August 2025
Primary Completion Date: September 2026
Study Completion Date: April 2029
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Nedlands, AU, 6009
AU Woodville, AU, 5011
CN Chengdu, CN, 610041
KR Seongnam-si, KR, 13496
TH Bangkok, TH, 10400
TH Bangkok, TH, 10330
TH Banphaeo, TH, 74120
US, CA Santa Rosa, CA, US, 95403
US, GA Atlanta, GA, US, 30318
US, MD Baltimore, MD, US, 21231
US, TX Houston, TX, US, 77090
US, VA Fairfax, VA, US, 22031